Bristol-Myers Squibb Company
ELIQUIS® (apixaban) prevents conversion of prothrombin to thrombin and prolongs clotting time. Find information for healthcare professionals and patients.
nulojix® (belatacept) | webseite: das offizielle bristol-myers squibb nulojix online informationsangebot für fachkolleginnen und –kollegen. hier finden sie informationen und kontaktmöglichkeiten
In unserem Portal für Pflege in der Onkologie von Bristol-Myers Squibb finden Sie hilfreiche Hinweise für den Alltag von onkologischen Pflegekräften.
At Bristol-Myers Squibb, we’re committed to investigating the potential of immuno-oncology in *** research. Read more about our findings.
EMPLICITI® (elotuzumab) is a prescription medicine used to treat certain ***s with relapsed/refractory multiple myeloma with pomalidomide/dexamethasone or with lenalidomide/dexamethasone. Please see Indication and Important Safety Information.
Search for clinical trials near you, find answers, and connect with patients at BMS Study Connect.
1 AVC sur 5 est dû à la fibrillation auriculaire. Pour diminuer le risque d’AVC, dès 65 ans, prenez le bon rythme, faites-vous dépister pour la FA !
Welcome to BMS-Optimal. Video guides for patients with rheumatoid arthritis (RA) who have been prescribed, currently preparing or receiving treatment with Orencia (abatacept) to be administered with the ClickJect pre-filled pen or pre-filled syringe.
1 CVA op 5 wordt veroorzaakt door voorkamerfibrillatie. Om het risico op CVA te verminderen, kies vanaf je 65ste het juiste ritme en laat je testen op VKF.
learn about the involvement of grey matter and white matter in multiple sclerosis. read how the loss of grey matter and presence of grey matter lesions may be involved with multiple sclerosis cognitive deficits.
